EANS-Adhoc: Card Guard subsidiary LifeWatch Inc. Launches Next Generation Wireless LifeStar ACT ExTM with Advanced Holter Analysis and Storage

--------------------------------------------------------------------------------
Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer
europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich.
--------------------------------------------------------------------------------

Neue Produkte/LifeStar ACT EX

11.05.2009

Neuhausen am Rheinfall / Switzerland and Chicago / USA, May 12, 2009
- Card Guard AG's (SIX Swiss Exchange: CARDG) American subsidiary
LifeWatch Services, Inc., the leading provider of wireless
telemedicine services in the U.S., announces the launch of its
next-generation wireless Ambulatory Cardiac Telemetry. The LifeStar
ACT ExTM with advanced Holter analysis will broaden the utilization
of ambulatory cardiac telemetry, add real-time auto-trigger and
auto-send to the traditional Holter service model and allow the
physician to use a single device for multiple purposes.

The launch of LifeWatch's first-to-market wireless LifeStar ACT Ex
using its 3- channel ambulatory cardiac telemetry platform, boasts
the ability to remotely retrieve up to 48 hours of digital Holter
data for near real time analysis. With its 30 day storage capability,
it can also provide a retrospective Holter analysis upon device
retrieval for as much as a 7-day period. The clinical significance of
this unique capability includes the following:

. Immediate notification of abnormal, life threatening arrhythmias using ACT
auto-trigger, auto send features

. Data can be remotely retrieved using cellular technology for real-time
analysis

. Aid in the accurate diagnosis and quantification of Atrial Fibrillation
(AF) and other cardiac rhythm disturbances, inclusive of AF burden for
physicians treating patients with AF and those patients who have had
strokes with an unknown origin

. Detailed ECG analysis surrounding a particular arrhythmia event in order
to accurately identify its origin and tailor a treatment plan specific to
the patient

. Detailed ECG analysis includes ability to analyze the QT segment of the
heart beat which can be an indicator of increased vulnerability for
lethal arrhythmias and can result in loss of consciousness, and
potentially sudden cardiac death

This innovation may obviate the need for emergency department
evaluation and hospital admissions, thus fulfilling the promise of
TeleHealth for outpatient diagnosis and management of patients with
cardiac arrhythmias. The ACT Ex simplistic functionality increases
the ease of use for patients for better compliance, while providing
the most comprehensive cardiac monitoring solution in the market.

"Despite its very low diagnostic yield (6%), the 24-48 hour Holter
test has been the predominant test of choice and utilized by most
physicians for arrhythmia diagnosis and management. The ACT Ex, with
its blended Holter analysis and auto-detect/auto-trigger capabilities
allows for the same analysis with improved yield. Its ability to
extend the monitoring period up to 7 days and potentially weeks at a
time will dramatically improve diagnostic yield. Furthermore, the
longer monitoring period allows for the accurate assessment of the
patient's rhythm disturbance during the course of normal daily
activities. Important information such as the adequacy of rate
control during persistent AF, AF burden following an intervention
such as the administration of an anti- arrhythmic medication or
catheter or surgical ablation can be obtained," stated Harry
Kopelman, M.D., LifeWatch Medical Advisory Board Chairman.

Dr. Yacov Geva, Chairman and CEO of Card Guard AG, stated, "Our
mission is to develop the most accurate and convenient wireless
patient monitoring technologies and clinical services in the industry
that have the ability to capture and deliver critical data for faster
time to treatment and higher diagnostic yield. The unique features of
the ACT Ex were developed in consultation with our esteemed Medical
Advisory Board".

Upcoming Card Guard Events

18 May 2009 Analysts' and Media conference Results Q1 2009

26 May 2009 Annual Shareholder Meeting of Card Guard AG in Zurich

About Card Guard AG

Card Guard AG, headquartered in Neuhausen am Rheinfall, Switzerland,
is a leading healthcare technology and solution company, specializing
in advanced telehealth systems and wireless cardiac monitoring
services. Card Guard services treat high-risk and chronically ill
patients, health conscious consumers and wellness programs. Card
Guard has subsidiaries in the United States, the Netherlands, Japan,
the United Kingdom, Switzerland and Israel. Card Guard AG is the
parent company of LifeWatch Services Inc., a leading US- based
cardiac monitoring service provider, and LifeWatch Technologies Inc.,
a US-based manufacturer of telecardiology products. www.cardguard.com

About LifeWatch Corp.

LifeWatch is a wholly owned subsidiary of Card Guard AG, a leading
healthcare technology and solutions provider listed on SIX Swiss
Stock Exchange (CARDG). LifeWatch Corp., through its operating
subsidiaries LifeWatch Services, Inc. and LifeWatch Technologies,
Inc. (Instromedix) is an independent provider of ambulatory cardiac
monitoring services and a manufacturer and distributor of ambulatory
cardiac and vital signs monitoring devices in the United States. Its
current services are used by physicians primarily to monitor patients
who are suspected of having heart rhythm disorders, or cardiac
arrhythmias, and its products are used by itself and by others in
connection with providing cardiac monitoring services. For more
information, visit: www.lifewatch.com. Sign-up for customized E-mail
alerts and documentation requests is available at

http://www.cardguard.com/newsite/inner.asp?cat=38&type=2&lang=1&mal=y
es

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. Card Guard AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to Card Guard AG at the
time of the issue of this press release. Card Guard AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF CARD
GUARD AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR
AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF CARD
GUARD AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF CARD GUARD AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM CARD GUARD AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Ende der Mitteilung euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Card Guard AG
Im Internet recherchierbar: http://www.presseportal.de

Rückfragehinweis:

For further information please contact:

Kobi Ben Efraim

Chief Financial Officer

Tel +41 52 632 00 50 | Fax +41 52 632 00 51

Email kobibe@cardguard.com

Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12

Email cardguard@sensus.ch

Branche: Gesundheitsdienste
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market (Freiverkehr) / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / Freiverkehr